CID 53252276

Mivavotinib

Structural Information

Molecular Formula
C17H21FN6O
SMILES
CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)N[C@@H]4CCCC[C@@H]4N
InChI
InChI=1S/C17H21FN6O/c1-24-8-9(6-21-24)15-13-10(7-20-17(13)25)14(18)16(23-15)22-12-5-3-2-4-11(12)19/h6,8,11-12H,2-5,7,19H2,1H3,(H,20,25)(H,22,23)/t11-,12+/m0/s1
InChIKey
MJHOMTRKVMKCNE-NWDGAFQWSA-N
Compound name
6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

9
References

631
Patents

344.1761 Da
Monoisotopic Mass

0.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 345.18338 180.6
[M+Na]+ 367.16532 189.4
[M+NH4]+ 362.20992 185.7
[M+K]+ 383.13926 188.1
[M-H]- 343.16882 182.5
[M+Na-2H]- 365.15077 183.6
[M]+ 344.17555 181.7
[M]- 344.17665 181.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe